ArticleBMC cancer2025
Iodized oil marking guided biopsy of hepatic space-occupying lesions under the protection of hepatic artery catheterization.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo investigate the efficacy and safety of iodized oil marking-guided percutaneous biopsy for hepatic space-occupying lesions under hepatic arterial catheter protection.
methodsA retrospective analysis was performed on 39 patients who underwent iodized oil marking-guided percutaneous biopsy of hepatic space-occupying lesions with hepatic arterial catheter protection. Pathological diagnostic results and postoperative complications were evaluated.
resultsAll 39 lesions were successfully marked with iodized oil, and tissue samples were obtained without technical failure. Of these, 35 cases were pathologically positive, yielding a positivity rate of 89.7% and a true-positive rate of 100%. Four cases were pathologically negative, among which one was later confirmed as a false negative, resulting in a false-negative rate of 25% and an overall diagnostic accuracy of 97.4%. Minor postoperative complications occurred in 13 patients, including abdominal pain in 10 cases (25.6%) and subcapsular microbleeding in 3 cases (7.7%), all of which resolved with symptomatic treatment without the need for special intervention. One case (2.6%) of hepatic arterial bleeding was successfully managed with emergency transcatheter arterial embolization, with no serious adverse events reported.
conclusionsIodized oil marking-guided percutaneous biopsy with hepatic arterial catheterization for hemorrhage control is effective and safe for hepatic space-occupying lesions. It enhances lesion localization, reduces operator dependence, and enables immediate hemostasis, making it suitable for high-risk or difficult-to-localize lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.